Trial
NCT04729205
Assessment of Safety and Therapeutic Efficacy of Promitil in Combination With Folfox in Patients With GI Malignancies
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Lipomedix Pharmaceuticals Inc.
Collaborators
—
Condition
Cancer
Intervention
Promitil
Why stopped
Investigational drug not available
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-09-14